Jump to content

Search the hub

Showing results for tags 'Standards'.


More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Digital health and care service provision
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Digital health and care service provision
    • Artificial Intelligence
    • Apps for health and care
    • Teleservices
    • Other health and care software
    • Digital health regulatory bodies/standards/guidance
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Patient Safety Alerts
    • Safety stories
    • Stories from the front line
    • Transformative Simulation
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Country


About me


Organisation


Role

Found 425 results
  1. Content Article
    The letter attached is from Professor Catherine Ross, Chief Scientific Officer for Scottish Government, with an update on the work relating to ‘Healthcare Science in Scotland’ and the theme of ‘quality, safety and, assurance’ as set out in Healthcare Science in Scotland: Defining Our Strategic Approach.    The Scottish Government has commissioned the Professional Standards Authority (PSA) to carry out a Right Touch Assurance (RTA) assessment of the Healthcare Science workforce. This work will examine the potential risk of harm to patients, particularly as many roles in Healthcare Science are not currently subject to statutory regulation. The assessment aims to inform future decisions about whether additional regulation may be needed to strengthen quality, safety and assurance across the profession. Stakeholder engagement will form a key part of the process, with opportunities to contribute evidence and views. A final report is expected by Spring 2027, after which the Scottish Government will consider next steps.
  2. Content Article
    The rapid development and use of artificial intelligence (AI) in health and social care raises professional, ethical and legal questions. In February, the Professional Standards Authority for Health and Social Care hosted a participatory workshop in collaboration with academics from the University of Bristol, Dr Helen Smith and Professor Jonathan Ives to explore how we can guide and regulate health and care professionals who use AI. The workshop brought together professional regulators and Accredited Registers, as well as patients, service users and members of the public. Through group discussions and a series of real-world scenarios, participants explored themes such as AI safety, bias, transparency and accountability. In this blog, Patrick Murphy, Policy Advisor, reflects on the messages that came out of the workshop. The value of lived experience The workshop reinforced a key message, that the future of AI in health and care cannot be shaped by technical expertise alone. Creating spaces where patients and service users work alongside regulators and Accredited Registers supports safer innovation. Lived experience brings vital insight into how systems work in practice, where risks can emerge, what the public want and need from regulation, and how to build trust. It also helps support the safe and reliable integration of AI. The workshop was designed with participation in mind. Patients and service users took part alongside regulators and accredited registers on an equal footing. In a space that can sometimes feel highly technical, the workshop showed that meaningful public involvement is both possible and necessary. Participants with lived experience engaged confidently with topics such as assurance, transparency and accountability. Discussions also covered how regulation, standards and guidance are experienced by the people they are meant to serve. A consistent message throughout the day was that patients and service users are not just observers of AI policy and regulation, they are essential partners in getting it right. Their contributions raised practical questions and real-world examples, and kept the focus on how AI-enabled decisions can affect people’s lives, access to services and confidence in care. Equity, transparency and trust Patients, service users and members of the public highlighted several issues that deserve particular attention as AI becomes more common across health and care. If engagement only reaches the most confident, connected or well-resourced groups, AI tools and the rules around them risk being shaped by a narrow range of experience. True inclusion means actively involving people who are often overlooked, so innovation serves everyone and not just those who are easiest to reach. To support safe and fair innovation, tackling inequality needs to be built into every stage, from development, to procurement and service design, to long-term monitoring after deployment. Fairness and equity must be central, not an afterthought. Avoiding harm requires more than technical fixes. It also needs careful scrutiny of the data that feeds AI systems. That includes the data used to train models and the data used in designing health and care services. It is also essential to be clear about which outcomes are being measured and how success is defined. Trust depends on clarity, and it is important to give consideration to how AI is integrated in health and social care. Patients and service users should not feel like they are interacting with a 'black box'. It should be clear when AI is being used, what role it is playing in someone’s care and what options are available if something feels wrong. Empowering people helps them remain partners in their own health and care journey. The workshop highlighted challenges but also the opportunities for health and social care improvement presented by AI. As we navigate this technological transformation, patients and service users should remain empowered through co-production, helping to shape the standards, guidance and regulation that govern how AI is designed, deployed and monitored in practice. To find out more about the workshop and read the report, visit: Artificial intelligence - how to guide and regulate for health and social care professionals using AI
  3. News Article
    Tens of thousands of therapy sessions are still being carried out by unaccredited practitioners in the NHS, data suggests – nearly four years after a deadline to stamp this out. The situation has been called “concerning” by a leading psychology body, who warned expansion of mental health care should “not come at the expense” of patient safety. The data relates to talking therapies in mental health care, such as cognitive behavioural therapy, typically delivered over a number of sessions. More than 40,600 out of 227,800 appointments – nearly a fifth - were carried out by a therapist who was not accredited or in training, according to the latest NHS England data for February this year. This information was unknown for nearly 300,000 more sessions. NHSE previously set a deadline for all counsellors delivering NHS-funded care to be accredited or in training by mid-2022. But Rebecca Light from the British Association for Behavioural and Cognitive Psychotherapies said: “It is concerning that a substantial number of interventions continue to be delivered by practitioners who are not yet registered or accredited.” The chief accreditation officer and registrar said: “As demand for mental health services continues to grow, it is vital that workforce expansion is matched by consistent standards across services. “Strengthening the use of accredited registers, alongside supporting practitioners to achieve and maintain accreditation, will help ensure that increased access to care does not come at the expense of quality or patient safety.” Read full story (paywalled) Source: HSJ, 7 March 2026
  4. Content Article
    Martin Fletcher, hub topic lead for professionalisation and regulation, has been part of transformational change in professional regulation through his tenure as Chief Executive of the Australian Health Practitioner Regulation Agency (Ahpra). In a new blog for the hub, Martin asks: How do we better connect the work of professional regulation with a systems focus on improving patient safety? And how do we navigate this interface in a health and societal context which is rapidly changing? Zubin Austin writes eloquently about the challenges of the ‘chaotic tumult’ of the many wicked problems that face professional regulators and, indeed, our health system more widely.[1] These form both the context and scaffolding for our work in years to come. The rise of entrepreneurial and profit-driven models of care, telehealth, unregulated medicines for sale online, the role of social media and AI-driven therapeutics are disruptors which have introduced new risk profiles. Traditional regulatory frameworks and approaches to patient safety must adapt. These shifts demand new thinking around safety, accountability, transparency and equity. Traditionally, professional regulation has more narrowly focused on the conduct, competence and performance of individual health practitioners, with an emphasis on public protection. However, we know that the safety of patients is shaped by a wider range of inter-related factors, including clinical governance, team dynamics, design of systems and processes, technology and organisational safety culture. There can be no healthcare without a health workforce. And an ethical, safety-conscious, competent and accountable health workforce is critical for a safe, high quality healthcare system. I have previously written for Patient Safety Learning on the need to more closely link the work of service, product and system regulators, and patient safety improvement bodies. Shared goals, role clarity, information flows and aligned actions are critical. When we operate in silos, we risk missing the bigger picture. Without coordinated action across agencies, patients remain vulnerable. The rapidly growing cosmetic practices sector illustrates these challenges vividly. In both Australia and the UK, reviews have shown that regulating practitioners alone isn’t enough.[2] [3] Products, procedures, facilities, social media, information asymmetry, service licensing arrangements and weak professional ethics all contribute to the potential risk of harm to patients. More widely, there are significant opportunities to better use and share data and intelligence to both anticipate and understand risks of patient harm. The legalisation of medicinal cannabis in Australia powerfully illustrates this need. Incident reports, notifications and complaints are often lag indicators—we need to get ahead of emerging risks of harm to patients, especially in the face of the many healthcare disruptors we face. I hope the hub community is a vehicle for sharing ideas, strategies and real-world examples of how to build foundations and bridges between professional regulation and patient safety improvements more widely. New thinking and approaches are needed. And despite many differences in the way that health systems are organised and funded across the world, there are many common challenges. References Austin Z, Haji A. Regulation of wicked problems: opportunities, responsibilities, and threats. J Med Regulation. 2023;109(3):6–11. doi:10.30770/2572-1852-109.3.6. Brown A, Duggan A, Kirkland A, McCausland R. Independent review of the regulation of medical practitioners who perform cosmetic surgery: Final report. Melbourne: Australian Health Practitioner Regulation Agency; August 2022. UK Parliament. The regulation of non-surgical cosmetic procedures in England. House of Commons Library, 10 September 2025. Further blogs on the hub from Martin Professional regulation and patient safety systems: parallel planets or partners in improvement?
  5. Content Article
    Surgical implants, such as joint replacements, are used for many serious conditions. Innovation continues to supply new implants, including outputs of the soft robotics revolution. However, they carry risk of complications with potentially devastating consequences. This opinion paper provides the reflections of two surgical technologists on present challenges to safety, efficacy and broad implementation of medical implants. They highlight lack of familiarity with implant surgery in healthcare services, with concomitant risk. First-in-human application of new implants is not sufficiently standardised and regulated. IDEAL-D is a structured framework for medical devices (Idea, Development, Exploration, Assessment, Long-term study). Once CE-marked and approved for mainstream use, there are problems with the implementation. ‘Early adopter’ surgeons and centres face cultural inertia, lack of funding support and issues around training, especially learning curves. Patient selection may not be well-defined, and complications inaccurately reported, affecting implant dissemination detrimentally. The Cumberlege report showed how harmful this can be. There is need to standardise early clinical studies. Implementation of implantable devices requires changes to whole-team training, funding and post-implementation reporting. The IDEAL-D framework represents an important step, but other system-wide changes are required if implants are to achieve their intended clinical impact.
  6. Content Article
    Protocols, targets and pathways save lives. They give us essential structure to deliver safe, high‑volume care with finite resources, and they have transformed the NHS for the better. But as the healthcare experience becomes increasingly streamlined, Hannah Little, Assistant Chief Nursing Officer at North Bristol NHS Trust, asks: who are we leaving behind? One size rarely fits all We often hear about what healthcare can learn from efficiency‑led industries such as automotive manufacturing, where success is defined by pace, scale and uniform outcomes. And indeed, cross‑industry learning has benefited the NHS enormously. But context matters. People are not cars rolling off a production line. We are complex, diverse human beings with individual social, psychological and clinical needs. And I wonder how far we can push a target‑driven model before we start hearing louder public concern about the fact that, in healthcare, one size rarely fits all. Finding the sweet spot As a nurse, I see individuals deliver personalised care brilliantly. I see colleagues who instinctively adapt, interpret and flex protocols to truly meet the needs of their patients and families. What worries me is not the people—it’s systems that increasingly constrains them. There is a 'sweet spot' between regulation, targets and national mandate on one side, and freedom to innovate on the other. That tension is necessary: too much control and we lose space for creativity; too little and we invite unsafe variation. When the balance is right, systems evolve safely, testing change within a clear structure while allowing for the flexibility that person‑centred care requires. The weight of national targets Standards and strong governance are essential to quality. But how do we ensure they don’t swallow the space needed for anything else? Over recent decades, the weight of national targets has grown heavier. The NHS Oversight Framework was intended to bring much‑needed clarity—a more focused set of national priorities that would reduce noise and strengthen local autonomy. At the 2026 Patient Safety Forum, national leaders spoke about a welcome cultural shift away from over‑mandating and toward local devolution. But this shift appears to be landing alongside a net reduction in resource and ever higher stakes to deliver. So instead of fewer mandates and more autonomy, we may be facing fewer mandates and less capacity for innovation. This raises a critical question: after the targets are met, is there enough resource left for the other things that matter? The things that support sustained performance? Targets tend to serve the 80% who fit neatly onto the healthcare conveyor belt. Without additional support for those who don’t, we risk widening health inequalities. Equity requires adaptability to be hard-wired into pathways—and adaptability requires headroom. The trade-offs Are we comfortable with where we are now? Has the pendulum swung into the place we need for 2026? Everyone recognises that resources are limited. But when limited resources necessitate laser focus on a small number of priorities, are the trade‑offs services have to make the right ones for population health? What will we think, looking back in five to ten years? Will we feel confident that a model which rewards optimising delivery for the majority was worth potentially widening the gap for those who didn’t fit standard pathways? Unlike other industries (e.g. Apple, which famously narrowed its product line to recover focus), healthcare cannot simply do fewer things well. Complex populations do not disappear because they fall outside a national priority. When centrally governed targets narrow without a corresponding rise in local capacity, the burden of adapting care falls to already stretched individuals. And when that happens, quality, equity and outcomes inevitably feel the strain. So what is the solution? If we care about equity and the safety and health of whole populations, resource to adapt and personalise care needs to be preserved. We need open, honest analysis of the trade-offs being made at policy level. Do we have the right set of priorities? Are we incentivising organisations to only pick low‑hanging fruit? And crucially: are we preserving the resource required to deliver personalised, equitable care? Passionate individuals cannot carry this burden alone. Flexibility must be designed into the system, not left to chance. And perhaps the answer is not fewer targets—but targets that incentivise equity as much as efficiency. Call to action Policymakers and senior leaders must prioritise embedding flexibility within national frameworks for all sectors by protecting resource for personalised care, incentivising equity alongside efficiency and enabling local systems to adapt. Without deliberate action, we risk incentivising services that work well for many, but fail those most in need.
  7. Content Article
    The Professional Standards Authority for Health and Social Care (PSA) has launched its Strategic Plan for 2026-29, setting out how it will encourage a more preventative approach to regulation through delivery of its statutory duties to help meet the challenges of today’s rapidly changing health and social care landscape. At its heart, the plan reaffirms the PSA’s unwavering commitment to protecting the public. It recognises that regulation can best support safe, effective care when it is targeted, proportionate and preventative, and when it works as part of a wider safety and quality system. PSA's strategic plan identifies five strategic themes around their work: oversight prevention reform governance collaboration. The plan contains three strategic aims: delivering highly effective oversight of regulation and registration driving continuous improvement across regulators and Accredited Registers working with others to make the overall system more cohesive, supportive and preventative. It also sets out how the PSA will support governments to maximise the benefits of a more modern and flexible legislative framework while remaining agile in prioritising work that delivers the greatest benefit for patients, service users and the public across England, Northern Ireland, Scotland and Wales.
  8. Content Article
    A study supported by the NIHR North West London PSRC examined the implementation of the Scan4Safety programme at an NHS demonstrator site to understand the hospital experience of adopting barcoding technologies and standards to improve patient safety and quality of care. Researchers found that using standardised data to identify patients, products, places and procedures, Scan4Safety helps build a robust information infrastructure across both internal and external hospital supply chains, with the potential to deliver significant value to patients, clinicians and the NHS. Related reading on the hub: Using barcode scanning technology to improve blood group testing in unborn babies Patient barcode scanning in NHS hospitals: safety, snags and workarounds. A nurse’s perspective
  9. Content Article
    This guidance sets out the relevant principles of good practice if you are involved in any criminal or regulatory proceedings, and want to know whether you should report this to the General Medical Council. 
  10. Content Article
    This month, the Professional Standards Authority have published their updated and combined Standards for the organisations they oversee and accredit. They are the result of extensive engagement, consultation and careful reflection. The Standards have been revised with one clear aim in mind—strengthening patient safety and public protection through robust professional regulation and registration. In this blog, Amanda Partington-Todd, Interim Director of Regulation and Accreditation, explains why the new Standards are good for patient safety.  Clearer expectations mean safer practice If our expectations of the professional regulators and Accredited Registers are unclear, it becomes harder to deliver them well. One of the most important changes we have made is to improve the clarity of our requirements by refining and streamlining the Standards. Clear standards support better decision making. They reduce ambiguity. And they help organisations focus on what really matters—protecting patients and the public, and maintaining public confidence in the health and care professions. The same safety bar for everyone We now have one single set of Standards for both professional health and care regulators and Accredited Registers. This is important. Different organisations operate in different ways. But when it comes to patient safety, the public should expect the same high standards, regardless of the type of body involved. By aligning our expectations, we are making it clear that the level of protection afforded to the public should not differ, even if regulators have legal powers that Accredited Registers do not. Strong governance and leadership protect patients Research and experience show that organisational culture and patient safety are closely linked. That is why the new Standards place consistent expectations on governance and leadership. Senior leaders must have appropriate oversight of how their organisations are run. They must understand the risks. And they must be accountable for how concerns are handled. Good governance helps create a culture where issues are identified early, concerns are taken seriously, and learning is embedded. That culture directly supports safer care. A stronger focus on risk and safeguarding Regulation exists to reduce the risk of harm. Our revised Standards strengthen expectations around evidence and risk-based decision-making, particularly in relation to professional suitability. This includes clearer expectations around safeguarding and appropriate checks, such as criminal records checks, where relevant. Safeguarding is not a technical requirement—it is fundamental to public safety. By reinforcing proportionate, risk-based approaches, the new Standards strengthen our expectations of how regulators and Accredited Registers assess professional suitability throughout a practitioner’s career, holding them to account for maintaining effective safeguards to protect the public. Better collaboration means fewer missed risks Patient safety can be undermined when information is not shared or when concerns are not addressed early. The new Standards encourage stronger collaboration and alignment across regulatory partners. By working together, sharing relevant information and reducing gaps between organisations, we can reduce the risk of missed opportunities to act. We also want to see concerns resolved as early and as locally as possible, where appropriate. Early action taken locally can prevent problems escalating; for example, by removing barriers to people raising complaints, and improve outcomes for patients and the public. Raising the bar from the very start For organisations applying to join our Accredited Registers programme, we have strengthened the tests we apply at the earliest stage. Improved eligibility requirements and clearer public interest assessments mean we can make the right decisions about which organisations are suitable for accreditation before they enter the programme. This early scrutiny strengthens public protection and supports confidence in the quality of Accredited Registers. Focused on impact, not just process Across all of these changes, one principle runs through the new Standards—regulation must make a real difference. It is not enough to have policies in place. The systems must work. Risks must be identified. Concerns must be handled fairly and effectively. Organisations must be willing to learn and improve. By clarifying expectations, aligning standards, strengthening governance, reinforcing safeguarding and encouraging collaboration, we have built a framework that is sharper, more consistent and more focused on outcomes. Patient safety depends on strong, effective regulation and registration. Our updated Standards are designed to achieve exactly that by driving continuous improvement and vigilance from the regulators and Accredited Registers. This ensures that regulation continues to protect the public and maintain confidence in health and care professions.
  11. Content Article
    Patient safety has become a central component of quality of care. One of the best known and most widely used security tools in all work settings is the checklists. The checklist is a tool that helps to not forget any step during the performance of a procedure, to do tasks with an established order, to control the fulfilment of a series of requirements or to collect data in a systematic way for its subsequent analysis. It is an aid to improve the efficiency of teamwork, promote communication, decrease variability, standardise care and improve patient safety. This article discusses the barriers in establishing checklists and the practical applications in paediatrics.
  12. Content Article
    By setting out 6 core standards, this guidance describes what NHS providers should have in place for the safe, effective and reliable implementation of Martha’s Rule. Standard 1: Reliable implementation and equitable access to all components of Martha’s Rule Intent To ensure that all 3 components of Martha’s Rule – patient wellness question, access to escalation and rapid clinical review – are implemented in line with guidance. All 3 components are operational and consistently accessible to patients, families, carers and staff in both adult and children’s inpatient settings in England. The patient wellness question is asked in line with adult, children and young people implementation guidance to ensure it is always asked in the same way (including response options) and the patient or family member’s direct response is recorded and actioned appropriately. Rapid reviews are carried out in line with guidance: reviewers are independent, appropriately skilled and can undertake or facilitate the review. Patients, families, carers and staff can reliably activate escalation and access rapid review. Self-assessment question Would patients, families, carers and staff be confident that all 3 components of Martha’s Rule are reliably available and implemented as intended? Standard 2: Rapid review conducted by independent, appropriately skilled clinicians Intent To ensure that when Martha’s Rule is activated, a rapid review is conducted or facilitated by an independent clinician with the appropriate skills. Rapid reviews are triggered promptly and involve a clinician not directly responsible for the patient’s ongoing care. The reviewing clinician has the appropriate skills to assess deterioration and either undertakes the review or facilitates timely access to the right clinician. The review focuses on the concerns raised and considers the patient’s condition in the round. All concerns raised by patients, families, carers and staff are listened to and acted on appropriately. Outcomes and any actions are communicated clearly to those who raised the concern, including patients and families. Self-assessment question If Martha’s Rule were activated today, would there be confidence that an independent clinician could review the patient and provide clear feedback to those involved? Standard 3: Meaningful involvement of patients, families, carers and staff in the patient wellness question and rapid review Intent To ensure that patients, families, carers and staff are meaningfully involved in the patient wellness question and the rapid review process, so concerns are accurately captured and acted on. Patients and families are made aware of the patient wellness question and understand its purpose and how their responses are used, whether within or outside an early warning system. Patients are always involved in the patient wellness question, other than in exceptional circumstances, for example when sedated. Older children who can engage are supported to answer the patient wellness question for themselves. Families or carers support patients with a learning disability or dementia or who are a very young child to answer the patient wellness question or provide relevant information. A staff member can advocate for such a patient who has no support. Where patients cannot engage directly, supportive tools such as soft signs of deterioration, observations or communication aids are used. During rapid review, patients, families, carers or staff who raised the concern are actively listened to, and their perspectives and responses are recorded and used to inform decisions about the patient’s care. Feedback from both the patient wellness question and rapid review is provided in a way that patients, families, carers and staff can understand and use. Staff understand their role in monitoring and escalating deterioration and how the patient wellness question will support their understanding of a patient’s condition over time. Self-assessment question Would patients, families, carers and staff report that their perspectives are actively sought, captured and used in both the patient wellness question and rapid review? Standard 4: Equitable access, awareness and understanding of Martha’s Rule Intent To ensure that patients, families, carers and staff are aware of Martha’s Rule and can access it fairly and consistently. All relevant groups are aware of Martha’s Rule and understand its purpose and how to access it. Martha’s Rule is promoted to all patients, families and carers, to ensure access is equitable across different needs, circumstances and clinical settings. Communication aids are readily available to support those whose first language is not English, who have low health literacy or who have a disability that limits access. Staff support patients and families to access Martha’s Rule. No patient, family member, carer or staff member is disadvantaged by language, disability, role, background, confidence or access to digital devices. Self-assessment question Would all relevant groups have equal opportunity to know about and access Martha’s Rule? Standard 5: Staff education, knowledge and understanding of Martha’s Rule Intent To ensure that all staff understand Martha’s Rule and their role in supporting it, have the confidence to recognise deterioration, involve patients, families and carers, and are able to activate and respond to the review process as appropriate. All staff understand the purpose and intent of all 3 components, including locum, agency and transient staff. Staff have the knowledge and the confidence to recognise changes in wellness and support patient, family and carer involvement. Staff know how to facilitate or activate escalation and rapid review. Staff understand how to involve patients who cannot self-report directly and older children appropriately. Staff feel empowered, supported and able to act when they have a concern or when concerns are raised with them. Self-assessment question Would staff feel confident that they understand Martha’s Rule, their role in the patient wellness question and escalation, and how to involve patients, families and carers appropriately? Standard 6: Embedding Martha’s Rule in governance and quality management systems Intent To ensure that Martha’s Rule is integrated into the organisation’s broader approach to patient safety, deteriorating patient management and quality improvement. Martha’s Rule is reflected in governance structures, quality management systems and strategies for patient deterioration. Martha’s Rule continues to be aligned with other patient safety initiatives around deterioration such as NEWS, NPEWS, NEWTT2 and MEWS. Responsibilities for oversight and review are clear. Martha’s Rule is embedded as a routine part of patient care, not a separate process. Data is submitted nationally and used locally to generate insight and continually improve patient outcomes, experiences and care. Feedback and learning from activations of Martha’s Rule is used to inform governance, quality management and staff training. Self-assessment question Would organisational leadership and governance structures be able to describe how Martha’s Rule contributes to patient safety and insight generation, and how improvements are identified and acted on?
  13. Content Article
    The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting members of the public to provide their views on proposals for the approach to recognising CE marked medical devices in Great Britain. The MHRA welcomes the views from anyone who will be impacted by the proposals, including medical device manufacturers and distributors, trade associations, regulatory experts, approved bodies, healthcare professionals including clinicians and those involved in procurement of medical devices, devolved administrations and patient representative organisations. MHRA are inviting views on the following proposals: Extending the current transitional arrangements for devices that comply with the Medical Device Directive (MDD) to align with the EU timelines for devices to transition from MDD to EU Medical Devices Regulation. Indefinitely recognising devices that comply with the EU Medical Device Regulation (EU MDR) and EU in vitro Diagnostic Medical Devices Regulation (EU IVDR). Introduction of an international reliance route for devices classified higher in Great Britain than in the EU. This consultation closes at 11:59pm on 10 April 2026.
  14. Event
    Members of the Patients for Patient Safety US network of Patient Safety Champions and Strategic Partners played a direct role in developing and advocating for the successful adoption of the Patient Safety Structural Measure (PSSM) into the Centers for Medicare and Medicaid Services (CMS) Quality Reporting Program. That was a landmark achievement, but the real work is just beginning. This webinar provides an update this, as beginning in April, hospital leaders will start submitting Attestation Statements to CMS indicating whether the 25 best practices specified in the PSSM are in place at their institutions. CMS will score these statements and publicly report the results for the first time later this year. Register here.
  15. Content Article
    The paper from Carl Macrae explores why safety recommendations in healthcare often fail to produce meaningful or sustained safety improvements. It identifies common problems in how recommendations are created, used, and managed, and proposes principles to improve their effectiveness. Eight problems with safety recommendations The Abundance Problem If safety recommendations are produced in large quantities and from many different sources, they can overwhelm recipients’ capacity to respond constructively and effectively. The Rigour Problem If safety recommendations are based on weak evidence and superficial, unsystematic or flawed analysis, they can misdirect improvement effort and attention to inconsequential issues. The Specificity Problem If safety recommendations make proposals that are under-specified and do not precisely articulate risks to be addressed, or are over-specified and target localised minutiae, they can cause scattered or myopic improvement efforts. The Integration Problem If safety recommendations are developed in isolation and without regard to connections with other recommendations, safety issues or ongoing work, they can deter or distract from systemic improvement activity. The Improvement Problem If safety recommendations present definitive solutions or corrective actions, they can preclude recipients from engaging in the collaborative, exploratory and locally adaptive work of learning. The Management Problem If safety recommendations are used as a tool for directing and managing action, they can degrade or marginalise local management capabilities and impede development of robust safety infrastructure. The Compliance Problem If safety recommendations issue mandatory or directive instructions, they can generate superficial compliance-oriented behaviour and box-ticking responses without addressing underlying risks. The Accountability Problem If safety recommendations are not supported by robust processes for allocating and monitoring accountabilities for improvement, they can dilute responsibility for effecting material change. Eight guiding principles Strategic Prioritisation: Recommendations are strategically selected and prioritised to target the most compelling and important risks. Careful consideration is given to any ongoing safety improvement activities, existing guidance or prior recommendations. Recommendations are prepared in a form that is actionable and accounts for recipients’ capacity and capabilities. Analytical Rigour: Recommendations are based on robust evidence and grounded in systematic investigation and analysis. Recommendations target meaningful risks and propose credible routes to safety improvement. The evidentiary basis and logic underlying specific recommendations can be clearly explained. Calibrated Specificity: Recommendations clearly articulate and describe the specific safety risks that are being targeted and which the recommendation seeks to address. The level of detail provided by recommendations is appropriate to the form and scale of action expected to be taken. Systemic Integration: Recommendations account for existing safety improvement activities and any related or planned recommendations. System-level safety priorities are considered with reference to activities of other bodies and organisations. Recommendations are aligned to, or integrated with, those from other organisations to support systemic improvement. Enabling Improvement: Recommendations encourage rigorous reflection and analysis and enable adaptive learning. Recipients are encouraged to rigorously explore, understand and address the risks targeted by recommendations. Safety innovation and collaborative learning are supported. Capability Enhancement: Recommendations build and enhance local safety management and governance processes. Recommendations are designed to support and strengthen the safety governance capabilities and capacity of recipients, developing safety competencies. Meaningful Engagement: Recommendations aim to generate genuine engagement with the challenge of addressing the safety risks being targeted. Thoughtful, reflective, rigorous and locally adaptive responses are supported and encouraged. Opportunities for narrow or superficial compliance are minimised. Active Accountability: Recommendations assign clear responsibilities for monitoring implementation and achieving safety improvement. Recommendations are monitored and managed through robust and transparent processes for tracking progress and meaningful change and safety improvement.
  16. Content Article
    Fitness to Practise is the process by which the Nursing and Midwifery Council (NMC) investigate concerns about the professionals on their Register and take action if it is required to protect the public. Fitness to Practise affects relatively few of our professionals but it can have significant consequences and is therefore subject to particular scrutiny. This publication provides new insights about: Why some cases about similar concerns receive more serious sanctions than others. What types of behaviours constitute dishonesty. Why some concerns raised by employers concluded at the initial stages, indicating that some concerns can be safely and fairly resolved locally. What was found Continuing rise in new concerns NMC have seen a 13% increase in the new concerns they received in the last year. The number of professionals on their Register increased by 3%. Members of the public continue to be the biggest source of concerns, but referrals from employers are increasing and returning to pre-pandemic levels. The number of Fitness to Practise concerns received each year involves less than 1% of the professionals on their Register. Concerns raised by employers Between 01 April 2024 and 31 March 2025, 15% of concerns which were closed after an initial assessment and did not progress beyond screening for regulatory investigation were raised by employers. The NMC want to work more closely with employers to support the right decisions about the concerns they can manage locally, and when a fair and appropriate referral is required. Making unnecessary Fitness to Practise referrals causes additional stress and worry for those involved. It also causes delays in the progression of other Fitness to Practise cases. The analysis of a sample of employers’ concerns found that just over half of employers in the sample had not used the employer advice line before making the referral, and that employers had been unable to complete local investigations for a quarter of the concerns because professionals had not engaged with the process. Outcomes at hearing stage Factors which result in the most serious sanctions include conduct which puts people risk of harm, a lack of insight into failings, a pattern of misconduct over time, and abuse of a position of trust. Dishonesty is one of the concerns most likely to result in a more serious sanction. The analysis reveals the types of behaviours that constitute dishonesty and some of the reasons expressed by professionals for this behaviour. A culture of learning It is important that professionals experience working environments and workplace cultures that enable them to speak up and report mistakes so that learning can be shared. This also prevents repetition of that mistake and enables the nurse, midwife or nursing associate to rectify errors immediately without fear of blame, bullying or harassment.
  17. Content Article
    The Professional Standards Authority for Health and Social Care (PSA) twice-yearly bulletin provides a valuable overview of the volume of learning points the PSA send and the themes identified. The PSA checks all final fitness practise decisions across the 10 health and social care regulators they oversee. This means they can highlight issues and identify themes. PSA regularly provide these to the regulators by way of learning points.  This can assist regulators in improving their decision-making processes. The learning points PSA identify will also be considered by their performance review team and explored in more detail as part of PSA's annual reviews on how the regulators are meeting their Standards of Good Regulation. PSA Learning Points Bulletin Issue 4 (March 2026) PSA Learning Points Bulletin Issue 3 (September 2025) PSA Learning Points Bulletin Issue 2 (February 2025) PSA Learning Points Bulletin Issue 1 (July 2024)
  18. Content Article
    In the first report of its type to be published, this report explains more about the Professional Standards Authority's role under Section 29 of the NHS Reform and Health Care Professions Act, including details about why and how they decide to appeal a regulator’s panel decision.  Using key data, comparative statistics, case studies and thematic insights, this report can be used by regulators for training their fitness to practise teams and panellists.
  19. Content Article
    The General Medical Council (GMC) may decide to investigate a concern about a doctor, physician associate (PA) or anaesthesia associate (AA) registered with them. Their website contains information about the support available as we know this can be a difficult and stressful time. It also explains their investigation processes and the actions they may take. Fitness to practise explained How we investigate concerns about doctors Doctors under investigation - Find out what support is available for doctors. And find out how the GMC investigation process works. Physician associates or anaesthesia associates under investigation - Find out what support is available for PAs or AAs. And find out how the GMC investigation process works. Hearings and decisions - Find the latest results of hearings and decisions by GMC and the Investigation Committee. Help for witnesses - Guide for witnesses helping the GMC with an investigation. It sets out how you can help, what to expect and the support available.
  20. Content Article
    In her first newsletter of 2026, Judy Walker discusses how After Action Review Conductors need to strike a balance between standardisation and authenticity through practicing self-awareness, setting adaptable ground rules and closing effectively
  21. Content Article
    The pharmaceutical industry plays a vital role in protecting human life and health. Medicines, vaccines and healthcare products directly impact millions of people around the world. Because of this, pharmaceutical companies must operate ethically and responsibly and social due diligence is becoming increasingly important. Social due diligence helps pharmaceutical companies identify, assess and manage social risks related to people, communities and ethical practices. It ensures that business operations respect human rights, employee welfare, patient safety and community well-being. Understanding social due diligence Social due diligence is a structured process used to evaluate how a company’s activities affect people. It focuses on social risks such as unsafe working conditions, unfair labour practices, community health impacts, and ethical issues in clinical trials and supply chains. In the pharmaceutical industry, where trust is critical, social due diligence is essential to maintain transparency, compliance and long-term sustainability. Why social due diligence is critical in the pharmaceutical industry 1. Protecting human rights and worker safety Pharmaceutical manufacturing involves chemical handling, laboratory work and high-risk processes. Social due diligence ensures: Safe working conditions. Fair wages and working hours. Protection from workplace hazards. This helps prevent accidents and promotes employee well-being. 2. Ethical clinical trials and ersearch Clinical trials involve human participants. Social due diligence ensures: Informed consent is properly taken. Participants are treated ethically. Vulnerable groups are protected. Ethical research practices build public trust and meet international standards. 3. Responsible supply chain management Pharmaceutical companies rely on global suppliers for raw materials and active ingredients. Social due diligence helps identify risks such as: Child or forced labour. Poor working conditions. Human rights violations. Monitoring suppliers ensures ethical sourcing and compliance. 4. Community health and social impact Manufacturing plants and research facilities affect nearby communities. Social due diligence evaluates: Community health risks. Access to healthcare. Social disruptions caused by operations. This helps companies reduce negative impacts and support local development. Key elements of social due diligence in pharmaceutical companies Employee welfare assessment This includes reviewing labour policies, safety standards, training programmes and grievance mechanisms to ensure employees are treated fairly and respectfully. Stakeholder engagement Engaging with employees, patients, regulators and local communities helps identify concerns early and improves decision-making. Risk identification and mitigation Social risks can be identified through audits, assessments and surveys. Companies can then create action plans to reduce or eliminate these risks. Compliance with regulations and standards Social due diligence ensures compliance with: National labour laws. International human rights standards. Industry-specific guidelines. Benefits of social due diligence for pharmaceutical companies Builds trust with patients and regulators. Reduces legal and reputational risks. Improves employee morale and productivity. Supports sustainable and ethical growth. Enhances brand credibility in global markets. Companies that invest in social due diligence are better prepared to face regulatory challenges and social expectations. Conclusion Social due diligence in the pharmaceutical industry is not just a regulatory requirement—it is a moral responsibility. By focusing on people, ethics and transparency, pharmaceutical companies can ensure safe operations, protect human rights and contribute positively to society. In an industry where human lives are at stake, responsible practices create long-term value and sustainable success. Social due diligence helps pharmaceutical companies move forward with integrity, accountability and trust.
  22. Content Article
    The US Agency for Healthcare Research and Quality (AHRQ) has established the AHRQ Surveys on Patient Safety Culture® (SOPS®) Ambulatory Surgery Center Database as a central repository for survey data from ambulatory surgery centres (ASCs) that have administered the AHRQ patient safety culture survey instrument and choose to submit their survey data to the AHRQ SOPS Ambulatory Surgery Centre Database. The database serves as an important resource for patient safety culture improvement. Participation is free and open to all SOPS ASC Survey users, provided the questionnaires are administered in a manner consistent with SOPS guidance and survey data are submitted according to SOPS specifications. The SOPS ASC Database contains data voluntarily submitted by participating ASCs and is not representative of all U.S. ASCs.
  23. News Article
    According to Qatar’s Ministry of Public Health (MoPH), the Ministry has launched the Qatar Patient Safety Classification as part of its strategic work to strengthen patient safety and improve the quality of healthcare services across the country. MoPH said the Classification is a unified national framework for classifying and analyzing patient safety information and clinical practice excellence across all healthcare facilities in Qatar. The Classification serves as the scientific foundation for the National Learning System for Patient Safety Events and Practice Excellence (NLS-PSEP). MoPH noted that it will help standardise health data, strengthen national-level analysis, and support continuous quality improvement across the health system. MoPH added that the framework aligns with Qatar National Vision 2030 and the National Health Strategy 2024–2030, and applies to all governmental, semi-governmental, and private healthcare facilities. It is intended for use by healthcare professionals, quality and patient safety teams, risk management teams, health leaders, regulators, and healthcare decision-makers. Dr. Eman Radwan, Acting Director of MoPH’s Healthcare Quality Department, said the launch is a major step toward improving healthcare quality and building a stronger culture of safety at the system level. She also noted that a national team developed the Classification, bringing together experts in healthcare quality and patient safety from both the public and private sectors in a partnership-based, integrated approach. MoPH explained that the Classification is intended to standardise patient safety concepts and taxonomies across the health system, strengthen national learning and reduce repeat incidents, improve risk management, enable comparative analysis and evidence-informed decision-making, and enhance transparency and public confidence in health services. MoPH also said implementation will support efforts to raise patient safety levels, strengthen a learning culture across providers, and reduce potential risks and harm at both facility and national levels. Read full story Source: OncoDaily, 13 January 2026
  24. Content Article
    Commissioned by NHS England Specialised Commissioning team in July 2024, this operational review of NHS adult gender dysphoria clinics (GDCs) in England was led by Dr David Levy, with the support of a panel of clinicians and other key stakeholders. The aim was to determine whether the operation and delivery of the GDCs meet the requirements of the non-surgical interventions service specification and consider the safety and effectiveness of the GDC service. The report sets out its key findings as follows: Access A majority of these clinics have exceptionally long waiting times for NHS services, with patients often waiting for many years to be assessed. This can be distressing for patients, place undue pressure on staff and contribute to patient safety risks. As the GDCs maintain separate waiting lists, the true size of the waiting list is unclear, as some patients may be referred to 1 or more GDC through self-referral or GP referral. The current referral process means the majority of GDCs need to manage relationships with GPs and other services outside their region or ICB area. This places additional demands on resources. Quality (including safety) The absence of any patient outcomes data, alongside limited and inconsistent quality data reporting, and minimal clinical audit makes it impossible to properly understand patient outcomes and the safety of these services. These gaps place these clinics outside standard NHS quality assurance expectations. In addition, existing patient demographic data and clinic feedback indicate that there has been a shift in patient demographics in recent years to a younger cohort with reported additional conditions. Yet, this has not always been met with corresponding changes in how some clinics identify and address patients’ potential additional biopsychosocial needs. Productivity There is currently a wide variation in service provision across the country. This includes differences in the number of appointments per GDC clinician and consultation length. These variations need to be considered both in terms of improving access and ensuring high-quality services and patient safety. Additional financial resources have been made available to each GDC to expand its staffing in recent years. However, workforce data has not always reflected an expansion in staff numbers in some GDCs. Culture, leadership and governance Some clinics undertake little or no quality improvement work or knowledge-sharing between services. The senior clinical leadership approach at some clinics also limits staff’s clinical curiosity and the opportunities to identify ways to improve patient outcomes. The review also found that oversight by some trust boards and by NHS England regional specialised commissioning teams has not consistently identified these concerns, sought any mitigating actions or supported improvements. This contributes to concerns that these services carry a high level of risk. Commissioners and host organisation oversight, governance and supportive leadership need to be strengthened to manage this risk. This will be critical to delivering improvements. Next steps Based on these findings, the review panel has set out twenty recommendations to improve patient care which are included in this report. The report calls for a wider healthcare response from national and local commissioning teams, adult gender dysphoria clinics, NHS trusts, ICBs, primary care, and other healthcare constituents. This joint approach will be driven by the proposed National Quality Improvement Programme for Adult Gender Services and a new National GDC Oversight Board.
  25. News Article
    A decade-long pattern of “systemic” leadership and governance failures led to avoidable patient harm in a trust’s breast cancer service, a highly critical review has found. The review of the service at County Durham and Darlington Foundation Trust found “sustained weakness” in the north east provider’s senior leadership and management team between 2012 and 2025. It was commissioned after concerns were raised about unnecessary mastectomies, excessive surgery, late diagnosis and missed opportunities for treatment, predominantly at the University Hospital of North Durham. Read full story (paywalled) Source: HSJ, 25 November 2025
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.